Ticker ACOR – Acorda Therapeutics, Inc. – description, marketcap, ebitda – Tickerday.com

ACOR

Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.

Number of employees: 344

Index: ; Marketcap: 33.37M; Income: ; Beta: 1.57

Dividend: ; Sales past 5 years: -13.70%; Sales qq: -36.30%

Types of investors:

Insiderown: 1.49%; Insidertrans: 0.00%; Institutionalown: ; Institutionaltrans: 0.00%

Margin:

Grossmargin: 83.10%; Opermargin: ; Profitmargin:

Ebitda (2015-2019): 59.9M 11.8M 145.66M 98.48M (82.03M)

Leave a comment

Your email address will not be published. Required fields are marked *